8. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sj gren's syndrome: a data-driven, expert consensus approach in the Sj gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken), 2012, 64:475-487.
[2]
9. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum, 2010, 62:2569-2581.
[3]
14. Archontogeorgis K, Steiropoulos P, Tzouvelekis A, et al. Lung cancer and interstitial lung diseases: a systematic review. Pulm Med, 2012, 2012:315918.
[4]
15. Song DH, Choi IH, Ha SY, et al. Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 cases. Korean J Pathol, 2014, 48:10-16.
[5]
16. Turner-Warwick M, Lebowitz M, Burrows B, et al. Cryptogenic fibrosing alveolitis and lung cancer. Thorax, 1980, 35:496-499.
[6]
18. Hill CL, Nguyen AM, Roder D, et al. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis, 2003, 62:728-731.
[7]
19. Gabrilovich M, Raza M, Dolan S, et al. Paraneoplastic polymyositis associated with squamous cell carcinoma of the lung. Chest, 2006, 129:1721-1723.
[8]
22. Watanabe A, Miyajima M, Mishina T, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen Thorac Cardiovasc Surg, 2013, 61:254-261.
[9]
23. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with outcome of patients with exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest, 2005, 128:3310-3315.
[10]
24. 张德平.特发性肺纤维化合并肺癌.中华结核和呼吸杂志, 2012, 35:647-649.
[11]
1. Bouros D, Hatzakis K, Labrakis H, et al. Association of malignancy with diseases causing interstitial pulmonary changes. Chest, 2002, 121:1278-1289.
[12]
4. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011, 183:788-824.
2. Watanabe N, Taniguchi H, Kondoh Y, et al. Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis. Respiration, 2013, 85:326-331.
[16]
3. Wells C, Mannino DM. Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J, 1996, 89:505-510.
[17]
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. New Engl J Med, 1975, 292(7-8):344-347, 403-407.
[18]
10. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum, 2013, 65:1-11.
[19]
11. Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol, 2007, 21:1011-1023.
[20]
12. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum, 2013, 65:2737-2747.
[21]
13. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007, 2:706-714.
[22]
17. Drakopanagiotakis F, Xifteri A, Polychronopoulos V, et al. Apoptosis in lung injury and fibrosis. Eur Respir J, 2008, 32:1631-1638.
[23]
20. Voltolini L, Bongiolatti S, Luzzi L, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg, 2013, 43:e17-23.
[24]
21. Saito Y, Kawai Y, Takahashi N, et al. Survival after surgery for pathologic stage ⅠA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. Ann Thorac Surg, 2011, 92:1812-1817.
[25]
25. Watanabe N, Taniguchi H, Kondoh Y, et al. Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis. Int J Clin Oncol, 2014, 19:260-265.
